methylthio-adp has been researched along with nitro-bis(2,4-pentanedionato)(pyridine)cobalt(iii) in 3 studies
| Studies (methylthio-adp) | Trials (methylthio-adp) | Recent Studies (post-2010) (methylthio-adp) | Studies (nitro-bis(2,4-pentanedionato)(pyridine)cobalt(iii)) | Trials (nitro-bis(2,4-pentanedionato)(pyridine)cobalt(iii)) | Recent Studies (post-2010) (nitro-bis(2,4-pentanedionato)(pyridine)cobalt(iii)) |
|---|---|---|---|---|---|
| 146 | 2 | 43 | 6 | 0 | 3 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fischer, B; Lévesque, SA; Nahum, V; Reiser, G; Sévigny, J; Tulapurkar, M | 1 |
| Camden, J; Fischer, B; Weisman, GA; Yelovitch, S | 1 |
| Azran, S; Danino, O; Fischer, B; Förster, D; Nadel, Y; Reiser, G | 1 |
3 other study(ies) available for methylthio-adp and nitro-bis(2,4-pentanedionato)(pyridine)cobalt(iii)
| Article | Year |
|---|---|
Diadenosine and diuridine poly(borano)phosphate analogues: synthesis, chemical and enzymatic stability, and activity at P2Y1 and P2Y2 receptors.
Topics: Adenosine; Animals; Boranes; Cell Line; Chlorocebus aethiops; Crystallography, X-Ray; Dinucleoside Phosphates; Drug Stability; Humans; Hydrolysis; Phosphoric Diester Hydrolases; Purinergic P2 Receptor Agonists; Pyrophosphatases; Rats; Receptors, Purinergic P2Y1; Receptors, Purinergic P2Y2; Uridine | 2006 |
Boranophosphate isoster controls P2Y-receptor subtype selectivity and metabolic stability of dinucleoside polyphosphate analogues.
Topics: Animals; Boranes; Calcium; Cell Line, Tumor; Dinucleoside Phosphates; Drug Stability; Humans; Hydrolysis; Models, Molecular; Molecular Conformation; Phosphoric Diester Hydrolases; Purinergic P2Y Receptor Agonists; Pyrophosphatases; Receptors, Purinergic P2Y; Stereoisomerism; Structure-Activity Relationship; Turkey | 2012 |
Highly efficient biocompatible neuroprotectants with dual activity as antioxidants and P2Y receptor agonists.
Topics: Animals; Antioxidants; Biocompatible Materials; Drug Design; Drug Stability; Humans; Hydrolysis; Models, Molecular; Neuroprotective Agents; Nucleotides; PC12 Cells; Protein Conformation; Purinergic P2Y Receptor Agonists; Rats; Reactive Oxygen Species; Receptors, Purinergic P2Y | 2013 |